CHI LONGEVITY (01863) announces its annual performance, with a net profit attributable to shareholders of 44.342 million yuan, representing a 20.18% decrease year-on-year.
China Dragon Sky Group (01863) announced its annual performance as of December 31, 2025. The group achieved revenue of 1.205 billion RMB (in the same unit), an increase of 3.41% year-on-year. The attributable net profit to the shareholders of the company was 44.342 million RMB, a decrease of 20.18% year-on-year. Earnings per share were 5.20 cents.
CHI LONGEVITY (01863) has announced its annual performance as of December 31, 2025. The group achieved a revenue of RMB 1.205 billion, representing a year-on-year increase of 3.41%. The profit attributable to owners of the company was RMB 44.342 million, a decrease of 20.18% year-on-year, with earnings per share of 5.20 cents.
The announcement stated that as of December 31, 2025, the group owned a total of 153 patents and/or copyrights, including 95 patents from Fujian Sijia (55 invention patents, 40 utility model patents), 39 patents from Shanghai Sijia (16 invention patents, 18 utility model patents), and 5 software copyrights. In addition, Fujian Sijia New Materials had 319 patents (5 invention patents, 14 utility model patents). The group continues to actively renew its patents every year to protect its intellectual property rights.
Related Articles
C SUCCESS FIN (03623) announced its annual performance with a net loss of 31.796 million RMB, narrowing by 43.9% year-on-year.
Jiangsu Guomao Reducer (603915.SH) plans to launch a restricted stock incentive plan in 2026.
BEST MART 360 (02360) announced its performance for 2025, with a net profit of HKD 220 million, a year-on-year decrease of 10.6%.
C SUCCESS FIN (03623) announced its annual performance with a net loss of 31.796 million RMB, narrowing by 43.9% year-on-year.
Jiangsu Guomao Reducer (603915.SH) plans to launch a restricted stock incentive plan in 2026.
BEST MART 360 (02360) announced its performance for 2025, with a net profit of HKD 220 million, a year-on-year decrease of 10.6%.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
